USPTO serial 99699117
CUZOWA
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CUZOWA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MINNEAPOLIS, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James A Wahl
James A Wahl Lathrop GPM LLP80 South 8th Street, 3100 IDS CenterMinneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2026 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Jun 3, 2026 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jun 2, 2026 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2026 | NWAP | NEW APPLICATION ENTERED | — |